MyoMaps1 offers the possibility of acquiring pixel-based quantitative myocardial tissue characteristics. Robustly, efficiently, and on the fly.
MyoMaps has the clinical potential to help you assess myocardial pathologies with new information, such as:
- Detection of global, diffuse and sometimes subtle myocardial pathologies (T1 Map).
- Depiction of cardiac edema (T2 Map).
- Detection of iron overload, guiding cardiovascular therapy - starting earlier and more efficiently (T2* Map).
Early clinical evidence:
New generation Cardiac Parametric Mapping: The Clinical Role of T1 and T2 Mapping.
Myocardial T1-Mapping: Techniques and Clinical Applications.
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.
"Myocardial T2 mapping is technically feasible and highly reproducible. It can detect focal edema and differentiate it from normal myocardium."
Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association.
1The product may not be commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens organization for further details.